| Operational resilience: concepts, design and analysis AA Ganin, E Massaro, A Gutfraind, N Steen, JM Keisler, A Kott, ... Scientific reports 6 (1), 1-12, 2016 | 352 | 2016 |
| Understanding terrorist organizations with a dynamic model A Gutfraind Studies in Conflict & Terrorism 32 (1), 45-59, 2009 | 58 | 2009 |
| Efficacy and optimization of palivizumab injection regimens against respiratory syncytial virus infection A Gutfraind, AP Galvani, LA Meyers JAMA pediatrics 169 (4), 341-348, 2015 | 56 | 2015 |
| Optimizing topological cascade resilience based on the structure of terrorist networks A Gutfraind PloS one 5 (11), e13448, 2010 | 54 | 2010 |
| Optimal interdiction of unreactive Markovian evaders A Gutfraind, A Hagberg, F Pan Integration of AI and OR Techniques in Constraint Programming for …, 2009 | 48 | 2009 |
| Multiscale network generation A Gutfraind, I Safro, LA Meyers 2015 18th international conference on information fusion (fusion), 158-165, 2015 | 47 | 2015 |
| Mathematical modeling of hepatitis C prevalence reduction with antiviral treatment scale-up in persons who inject drugs in metropolitan Chicago D Echevarria, A Gutfraind, B Boodram, M Major, S Del Valle, SJ Cotler, ... PloS one 10 (8), e0135901, 2015 | 41 | 2015 |
| Indication of Outreach Options for Healthcare Facility to Facilitate Patient Actions A McElhinney, A Gutfraind, N Bowers US Patent App. 14/836,652, 2017 | 40 | 2017 |
| Lanchester Theory and the Fate of Armed Revolts MP Atkinson, A Gutfraind, M Kress Arxiv preprint arXiv:1106.4358, 2011 | 39* | 2011 |
| Optimizing network topology for cascade resilience A Gutfraind Handbook of Optimization in Complex Networks: Communication and Social …, 2011 | 37 | 2011 |
| Risk analysis beyond vulnerability and resilience–characterizing the defensibility of critical systems V Bier, A Gutfraind European Journal of Operational Research 276 (2), 626-636, 2019 | 34 | 2019 |
| Agent-based model forecasts aging of the population of people who inject drugs in metropolitan Chicago and changing prevalence of hepatitis C infections A Gutfraind, B Boodram, N Prachand, A Hailegiorgis, H Dahari, ME Major PloS one 10 (9), e0137993, 2015 | 32 | 2015 |
| High-risk geographic mobility patterns among young urban and suburban persons who inject drugs and their injection network members B Boodram, AL Hotton, L Shekhtman, A Gutfraind, H Dahari Journal of Urban Health 95 (1), 71-82, 2018 | 31 | 2018 |
| Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia A Gutfraind, LA Meyers The Journal of infectious diseases 211 (8), 1262-1267, 2015 | 30 | 2015 |
| How do terrorist cells self-assemble: Insights from an agent-based model of radicalization M Genkin, A Gutfraind Available at SSRN 1031521, 2011 | 30 | 2011 |
| A graph database framework for covert network analysis: An application to the Islamic State network in Europe A Gutfraind, M Genkin Social Networks 51, 178-188, 2017 | 29 | 2017 |
| Optimizing distribution of pandemic influenza antiviral drugs B Singh, HC Huang, DP Morton, GP Johnson, A Gutfraind, AP Galvani, ... Emerging infectious diseases 21 (2), 251, 2015 | 27 | 2015 |
| Generating realistic scaled complex networks CL Staudt, M Hamann, A Gutfraind, I Safro, H Meyerhenke Applied Network Science 2, 1-29, 2017 | 25 | 2017 |
| Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections R Fu, A Gutfraind, ML Brandeau Mathematical biosciences 273, 102-113, 2016 | 22 | 2016 |
| Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users M Major, A Gutfraind, L Shekhtman, Q Cui, A Kachko, SJ Cotler, ... Science translational medicine 10 (449), eaao4496, 2018 | 21 | 2018 |
Harel DahariAssociate Professor, PhD, Loyola University Chicago Medical Center確認したメール アドレス: luc.edu